US 11603413
Anti-TMPRSS2 antibodies and antigen-binding fragments
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 11603413 (Anti-TMPRSS2 antibodies and antigen-binding fragments) held by REGENERON PHARMACEUTICALS, INC. expires Mon Mar 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Mar 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K2039/54, A61K9/0019